| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $9.4M | +22.8% |
| SG&A Expense | $6.5M | -23.4% |
| Operating Income | -$14.3M | +7.4% |
| Income Tax | $0 | — |
| Net Income | -$13.0M | +9.3% |
| EPS (Basic) | -$2.35 | +40.5% |
| EPS (Diluted) | -$2.45 | +38.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.8M | +5.8% |
| Current Assets | $23.6M | +4.7% |
| Total Assets | $24.0M | +5.9% |
| Current Liabilities | $3.4M | -23.4% |
| Stockholders' Equity | $19.3M | +13.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.6M | -11.3% |
| Capital Expenditures | $15K | -83.4% |
| Investing Cash Flow | -$15K | +83.4% |
| Financing Cash Flow | $14.8M | +188.4% |
| Free Cash Flow | -$13.6M | -10.6% |